AzTrials
AzTrials

Kidney StonesNCT07909577

Comparison of Smart Pressure-Controlled Flexible Ureteroscopy and Flexible Suction Ureteral Access Sheath-Assisted Flexible Ureteroscopy for 2-3 cm Renal Stones

A study testing Distal Flexible Suction Ureteral Access Sheath-Assisted Flexible Ureteroscopy in people with Kidney Stones, run by The First Affiliated Hospital of Guangzhou Medical University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective, multicenter, randomized, non-inferiority controlled trial aims to compare the efficacy and safety of smart pressure-controlled flexible ureteroscopy and flexible ureteroscopy assisted by a distal flexible suction ureteral access sheath in patients with 2-3 cm renal stones. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Kidney Stones
What is being tested?
Distal Flexible Suction Ureteral Access Sheath-Assisted Flexible Ureteroscopy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
750 participants
Where
No sites listed yet
Study dates
1 Nov 2026to 1 Nov 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18-75 years
  • Patients diagnosed with renal stones measuring 2-3 cm based on preoperative imaging
  • Unilateral renal stones suitable for flexible ureteroscopy
  • Eligible for surgical treatment under general anesthesia
  • Able and willing to provide written informed consent

Who cannot join

  • Patients with active urinary tract infection that has not been adequately treated
  • Patients with severe coagulation disorders or contraindications to surgery.
  • Patients with severe cardiopulmonary dysfunction or other conditions that make surgery unsafe.
  • Patients with anatomical abnormalities of the urinary tract that significantly affect the planned procedure.
  • Patients with bilateral renal stones requiring simultaneous bilateral treatment.
  • Pregnant or breastfeeding women.
  • Patients participating in other clinical studies that may interfere with this study.
  • Patients considered unsuitable for participation by the investigator.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

YongDa Liu, PhD contact

13719007083

13719007083@163.com

About this study

Official title: A Prospective, Multicenter, Randomized, Non-Inferiority Controlled Trial Comparing the Efficacy and Safety of Smart Pressure-Controlled Flexible Ureteroscopy and Flexible Ureteroscopy Assisted by a Distal Flexible Suction Ureteral Access Sheath for the Treatment of 2-3 cm Renal Stones

This prospective, multicenter, randomized, non-inferiority controlled trial aims to compare the efficacy and safety of smart pressure-controlled flexible ureteroscopy and flexible ureteroscopy assisted by a distal flexible suction ureteral access sheath in patients with 2-3 cm renal stones. Eligible patients will be randomly assigned to one of the two treatment groups. The primary objective is to determine whether smart pressure-controlled flexible ureteroscopy is non-inferior to the suction sheath-assisted approach in terms of stone-free rate. Secondary outcomes include operative time, postoperative complications, intrarenal pressure-related outcomes, length of hospital stay, and other relevant perioperative parameters. The findings are expected to provide clinical evidence to guide the selection of surgical techniques for patients with 2-3 cm renal stones.

Read the detailed description

This prospective, multicenter, randomized, non-inferiority controlled trial will evaluate the efficacy and safety of smart pressure-controlled flexible ureteroscopy compared with flexible ureteroscopy assisted by a distal flexible suction ureteral access sheath in patients with renal stones measuring 2-3 cm.

Eligible patients will be enrolled at participating centers and randomly assigned to one of two treatment groups. The intervention group will undergo flexible ureteroscopy using a smart pressure-control system, while the control group will undergo flexible ureteroscopy assisted by a distal flexible suction ureteral access sheath. Surgical procedures will be performed according to standardized protocols and the applicable instructions for use of the devices.

The primary outcome will be the stone-free rate, assessed using postoperative imaging at a prespecified follow-up time point. Secondary outcomes will include operative time, postoperative complications, changes in renal function where applicable, length of hospital stay, and other perioperative outcomes. Safety assessments will focus on intraoperative and postoperative adverse events, including infectious complications and ureteral injury.

The study will use a non-inferiority design to determine whether smart pressure-controlled flexible ureteroscopy achieves stone clearance outcomes that are not unacceptably worse than those of the distal flexible suction ureteral access sheath-assisted approach, while also evaluating comparative safety. The study results are expected to provide evidence to inform the choice of surgical technique for patients with 2-3 cm renal stones.

Conditions
Kidney Stones
Being tested
Smart Pressure-Controlled Flexible Ureteroscopy, Distal Flexible Suction Ureteral Access Sheath-Assisted Flexible Ureteroscopy
Keywords
Flexible ureteroscopy, kidney stones, Suction ureteral access sheath, Intrarenal pressure
Medical subject headings
Kidney Calculi

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Smart Pressure-Controlled Flexible UreteroscopyDevice

    Flexible ureteroscopy for the treatment of 2-3 cm renal stones using a smart pressure-control system to regulate intrarenal pressure during lithotripsy. The procedure will be performed according to the study protocol and the device instructions for use.

  • Distal Flexible Suction Ureteral Access Sheath-Assisted Flexible UreteroscopyDevice

    Flexible ureteroscopy for the treatment of 2-3 cm renal stones using a distal flexible suction ureteral access sheath to facilitate stone fragment evacuation and urinary drainage during lithotripsy. The procedure will be performed according to the study protocol and the device instructions for use.

Study groups in NCT07909577
Study groupRoleWhat they receive
Smart Pressure-Controlled Flexible UreteroscopyExperimentalParticipants will undergo flexible ureteroscopy using a smart pressure-control system for the treatment of 2-3 cm renal stones, according to the study protocol and device instructions for use.
Receives: Device: Smart Pressure-Controlled Flexible Ureteroscopy
Distal Flexible Suction Ureteral Access Sheath-Assisted Flexible UreteroscopyActive comparatorParticipants will undergo flexible ureteroscopy assisted by a distal flexible suction ureteral access sheath for the treatment of 2-3 cm renal stones, according to the study protocol and device instructions for use.
Receives: Device: Distal Flexible Suction Ureteral Access Sheath-Assisted Flexible Ureteroscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Immediate Stone-Free Rate

    The proportion of patients with no residual renal stone fragments or only clinically insignificant residual fragments, as defined in the study protocol, confirmed by postoperative imaging immediately after surgery. The immediate stone-free rate will be compared between the smart pressure-controlled flexible ureteroscopy group and the distal flexible suction ureteral access sheath-assisted flexible ureteroscopy group.

    Measured: Within 24 hours after surgery

  2. Postoperative Complication Rate

    The proportion of patients experiencing intraoperative or postoperative complications associated with the surgical procedure, including infectious complications, ureteral injury, bleeding, and other adverse events. Complications will be assessed and graded according to the Clavien-Dindo classification.

    Measured: From surgery to 30 days after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2026
  2. Study start1 Nov 2026 (estimated)
  3. Primary completion1 Jan 2027 (estimated)
  4. Study completion1 Nov 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned in a 1:1 ratio to two parallel treatment arms: smart pressure-controlled flexible ureteroscopy or flexible ureteroscopy assisted by a distal flexible suction ureteral access sheath. The efficacy and safety of the two approaches will be compared.
Masking
None (open label)
Enrolment
750 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07909577
Sponsor's protocol ID
GYFYZJH20261019
Status last verified
Oct 2026
First submitted
19 Oct 2026
Last updated
2 Nov 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Distal Flexible Suction Ureteral Access Sheath-Assisted Flexible Ureteroscopy in people with Kidney Stones, run by The First Affiliated Hospital of Guangzhou Medical University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact YongDa Liu, PhD (13719007083, 13719007083@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Immediate Stone-Free Rate (time frame: Within 24 hours after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in